Literature DB >> 24549061

New nomenclature for atypical chemokine receptors.

Françoise Bachelerie1, Gerard J Graham2, Massimo Locati3, Alberto Mantovani3, Philip M Murphy4, Robert Nibbs2, Antal Rot5, Silvano Sozzani6, Marcus Thelen7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24549061     DOI： 10.1038/ni.2812

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  16 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

2.  Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6.

Authors:  Anna M Fra; Massimo Locati; Karel Otero; Marina Sironi; Paola Signorelli; Maria L Massardi; Marco Gobbi; Annunciata Vecchi; Silvano Sozzani; Alberto Mantovani
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 3.  Tuning inflammation and immunity by chemokine sequestration: decoys and more.

Authors:  Alberto Mantovani; Raffaella Bonecchi; Massimo Locati
Journal:  Nat Rev Immunol       Date:  2006-12       Impact factor: 53.106

4.  CCRL2, a fringe member of the atypical chemoattractant receptor family.

Authors:  Annalisa Del Prete; Raffaella Bonecchi; Annunciata Vecchi; Alberto Mantovani; Silvano Sozzani
Journal:  Eur J Immunol       Date:  2013-05-10       Impact factor: 5.532

5.  Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.

Authors:  Sudarshan Rajagopal; Jihee Kim; Seungkirl Ahn; Stewart Craig; Christopher M Lam; Norma P Gerard; Craig Gerard; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-17       Impact factor: 11.205

6.  β-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6.

Authors:  Elena M Borroni; Cinzia Cancellieri; Alessandro Vacchini; Yann Benureau; Bernard Lagane; Françoise Bachelerie; Fernando Arenzana-Seisdedos; Kensaku Mizuno; Alberto Mantovani; Raffaella Bonecchi; Massimo Locati
Journal:  Sci Signal       Date:  2013-04-30       Impact factor: 8.192

7.  Control of chemokine-guided cell migration by ligand sequestration.

Authors:  Bijan Boldajipour; Harsha Mahabaleshwar; Elena Kardash; Michal Reichman-Fried; Heiko Blaser; Sofia Minina; Duncan Wilson; Qiling Xu; Erez Raz
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

8.  The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.

Authors:  Robert J B Nibbs; Derek S Gilchrist; Vicky King; Antonio Ferra; Steve Forrow; Keith D Hunter; Gerard J Graham
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 9.  Immune regulation by atypical chemokine receptors.

Authors:  Robert J B Nibbs; Gerard J Graham
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468
View more
  79 in total

Review 1.  Chemokines, their receptors and human disease: the good, the bad and the itchy.

Authors:  Vanessa L Bryant; Charlotte A Slade
Journal:  Immunol Cell Biol       Date:  2015-04       Impact factor: 5.126

Review 2.  Chemokine signaling in development and disease.

Authors:  John Wang; Holger Knaut
Journal:  Development       Date:  2014-11       Impact factor: 6.868

3.  Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.

Authors:  Martyna Szpakowska; Amanda M Nevins; Max Meyrath; David Rhainds; Thomas D'huys; François Guité-Vinet; Nadine Dupuis; Pierre-Arnaud Gauthier; Manuel Counson; Andrew Kleist; Geneviève St-Onge; Julien Hanson; Dominique Schols; Brian F Volkman; Nikolaus Heveker; Andy Chevigné
Journal:  Br J Pharmacol       Date:  2018-03-23       Impact factor: 8.739

4.  The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.

Authors:  Annalisa Del Prete; Francesca Sozio; Tiziana Schioppa; Andrea Ponzetta; William Vermi; Stefano Calza; Mattia Bugatti; Valentina Salvi; Giovanni Bernardini; Federica Benvenuti; Annunciata Vecchi; Barbara Bottazzi; Alberto Mantovani; Silvano Sozzani
Journal:  Cancer Immunol Res       Date:  2019-09-04       Impact factor: 11.151

Review 5.  Chemokine and chemotactic signals in dendritic cell migration.

Authors:  Laura Tiberio; Annalisa Del Prete; Tiziana Schioppa; Francesca Sozio; Daniela Bosisio; Silvano Sozzani
Journal:  Cell Mol Immunol       Date:  2018-03-21       Impact factor: 11.530

6.  Chemokines: the past, the present and the future.

Authors:  Peng Tang; Ji Ming Wang
Journal:  Cell Mol Immunol       Date:  2018-03-26       Impact factor: 11.530

Review 7.  Chemokines in homeostasis and diseases.

Authors:  Keqiang Chen; Zhiyao Bao; Peng Tang; Wanghua Gong; Teizo Yoshimura; Ji Ming Wang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 8.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

Review 9.  Kidney dendritic cells: fundamental biology and functional roles in health and disease.

Authors:  Christian Kurts; Florent Ginhoux; Ulf Panzer
Journal:  Nat Rev Nephrol       Date:  2020-05-05       Impact factor: 28.314

Review 10.  Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.

Authors:  K E Quinn; D I Mackie; K M Caron
Journal:  Cytokine       Date:  2018-09       Impact factor: 3.861
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.